These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35971514)

  • 1. Number of averted COVID-19 cases and deaths attributable to reduced risk in vaccinated individuals in Japan.
    Kayano T; Sasanami M; Kobayashi T; Ko YK; Otani K; Suzuki M; Nishiura H
    Lancet Reg Health West Pac; 2022 Nov; 28():100571. PubMed ID: 35971514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
    Haas EJ; McLaughlin JM; Khan F; Angulo FJ; Anis E; Lipsitch M; Singer SR; Mircus G; Brooks N; Smaja M; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet Infect Dis; 2022 Mar; 22(3):357-366. PubMed ID: 34562375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct impact of COVID-19 vaccination in Chile: averted cases, hospitalizations, ICU admissions, and deaths.
    Brault A; Hart A; Uribe P; Prado J; San Martín J; Maass A; Canals M
    BMC Infect Dis; 2024 May; 24(1):467. PubMed ID: 38698324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated COVID-19 severe cases and deaths averted in the first year of the vaccination campaign in Brazil: A retrospective observational study.
    Santos CVBD; Noronha TG; Werneck GL; Struchiner CJ; Villela DAM
    Lancet Reg Health Am; 2023 Jan; 17():100418. PubMed ID: 36575682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the number of severe COVID-19 cases and COVID-19-related deaths averted by a nationwide vaccination campaign in Republic of Korea.
    Hwang JH; Lee JH; Jang EJ; Kim RK; Lee KH; Park SK; Lee SE; Chae C; Lee S; Park YJ
    Osong Public Health Res Perspect; 2023 Jun; 14(3):164-172. PubMed ID: 37415433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study.
    Nygaard U; Holm M; Hartling UB; Glenthøj J; Schmidt LS; Nordly SB; Matthesen AT; von Linstow ML; Espenhain L
    Lancet Child Adolesc Health; 2022 Jul; 6(7):459-465. PubMed ID: 35526537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021-2022.
    Martínez-Baz I; Trobajo-Sanmartín C; Miqueleiz A; Egüés N; García Cenoz M; Casado I; Navascués A; Fernández-Huerta M; Echeverría A; Guevara M; Ezpeleta C; Castilla J
    Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran.
    Ghafari M; Hosseinpour S; Rezaee-Zavareh MS; Dascalu S; Rostamian S; Aramesh K; Madani K; Kordasti S
    BMC Med; 2023 Nov; 21(1):429. PubMed ID: 37953291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the COVID-19 vaccination program in Japan, 2021 using the counterfactual reproduction number.
    Kayano T; Ko Y; Otani K; Kobayashi T; Suzuki M; Nishiura H
    Sci Rep; 2023 Oct; 13(1):17762. PubMed ID: 37853098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
    PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of mRNA COVID-19 Vaccines in Japan during the Nationwide Pandemic of the Delta Variant.
    Akaishi T; Kushimoto S; Katori Y; Sugawara N; Igarashi K; Fujita M; Kure S; Takayama S; Abe M; Kikuchi A; Ishizawa K; Abe Y; Imai H; Inaba Y; Iwamatsu-Kobayashi Y; Nishioka T; Onodera K; Ishii T
    Tohoku J Exp Med; 2022 May; 257(1):1-6. PubMed ID: 35354690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection: an observational study from routine surveillance data in Switzerland.
    Anderegg N; Althaus CL; Colin S; Hauser A; Laube A; Mäusezahl M; Wagner M; Zaffora B; Riou J
    Swiss Med Wkly; 2022 Apr; 152():w30163. PubMed ID: 35752951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lives saved and hospitalizations averted by COVID-19 vaccination in New York City: a modeling study.
    Shoukat A; Vilches TN; Moghadas SM; Sah P; Schneider EC; Shaff J; Ternier A; Chokshi DA; Galvani AP
    Lancet Reg Health Am; 2022 Jan; 5():100085. PubMed ID: 34746912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Vaccination and Estimated Public Health Impact in California.
    Tan ST; Park HJ; Rodríguez-Barraquer I; Rutherford GW; Bibbins-Domingo K; Schechter R; Lo NC
    JAMA Netw Open; 2022 Apr; 5(4):e228526. PubMed ID: 35452106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 hospitalizations and deaths averted under an accelerated vaccination program in northeastern and southern regions of the USA.
    Vilches TN; Sah P; Moghadas SM; Shoukat A; Fitzpatrick MC; Hotez PJ; Schneider EC; Galvani AP
    Lancet Reg Health Am; 2022 Feb; 6():100147. PubMed ID: 34977848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study.
    Molteni E; Canas LS; Kläser K; Deng J; Bhopal SS; Hughes RC; Chen L; Murray B; Kerfoot E; Antonelli M; Sudre CH; Pujol JC; Polidori L; May A; Hammers PA; Wolf J; Spector PTD; Steves CJ; Ourselin PS; Absoud M; Modat M; Duncan PEL
    Lancet Reg Health Eur; 2022 Aug; 19():100429. PubMed ID: 35821715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.